The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.
These jobs will propel the province towards being a global leader in biomanufacturing and life sciences. MISSISSAUGA, ON, Nov ...
Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...
Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...
The Executive Vice-President, Diagnostics, Africa at Roche Diagnostics, Dr. Allan Pamba stated this in a statement to ...
Wish4Life Foundation, a US-based non-government organisation (NGO) dedicated to the care of children battling with cancer, is ...
Government funding will support 250 jobs in health-care technology at a Mississauga-based company. Hoffman-La Roche Limited’s ...
Kazmierczak also appreciates that flexibility. “Roche provides phenomenal work-life balance, with great benefits, making it ...
Neuron23 unveiled details around its global Phase 2 NEULARK clinical trial of NEU-411 in people with early Parkinson’s disease.
The Cancer Alliance intervenes in a landmark case against Roche, alleging excessive pricing of Trastuzumab, impacting thousands of South African women with breast cancer.
His executive experience spans global industry leaders including Abbott Diagnostics, Roche Molecular Diagnostics, and LifeTechnologies/Thermo Fisher, as well as public CEO roles at Clarient Inc and ...